Abstract
STOP PEDS is a pilot study of children with CF ages 6-18 across 10 sites in North America.
The primary goal is to assess the acceptability and feasibility of a multicenter randomized
trial comparing immediate antibiotics versus tailored therapy for pulmonary exacerbation
(PEx) treatment in this population.
